Skip to main content

Valturna FDA Approval History

FDA Approved: Yes (Discontinued) (First approved September 16, 2009)
Brand name: Valturna
Generic name: aliskiren and valsartan
Dosage form: Tablets
Company: Novartis Pharmaceuticals Corporation
Treatment for: High Blood Pressure

Marketing Status: Discontinued

Valturna is a combination of aliskiren (a direct renin inhibitor) and valsartan (an angiotensin II receptor blocker) indicated for the treatment of high blood pressure.

Development timeline for Valturna

Sep 17, 2009Approval Novartis receives FDA approval for Valturna, a single-pill combination of valsartan and aliskiren, to treat high blood pressure

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.